Prospects of Pharmacological Interventions to Organismal Aging

Abstract Intense research in the areas of cellular and organismal aging using diverse laboratory model systems has enriched our knowledge in the processes and the signalling pathways involved in normal and pathological conditions. The field finds itself in a position to take decisive steps towards clinical applications and interventions not only for targeted age-related diseases such as cardiovascular conditions and neurodegeneration but also for the modulation of health span and lifespan of a whole organism. Beyond nutritional interventions such as dietary restriction without malnutrition and various regimes of intermittent fasting, accumulating evidence provides promise for pharmacological interventions. The latter, mimic caloric or dietary restriction, tune cellular and organismal stress responses, affect the metabolism of microbiome with subsequent effects on the host or modulate repair pathways, among others. In this mini review, we summarise some of the evidence on drugs that can alter organismal lifespan and the prospects they might offer for promoting healthspan and delaying age-related diseases.

• Publication year

  2018

• Venue

  Biomolecular Concepts

• Publication date

  2018-12-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1515/bmc-2018-0018PMID 30676997
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High-Throughput Screens To Identify Autophagy Inducers That Function by Disrupting Beclin 1/Bcl-2 Binding.

  2018cited by this paper
• Resveratrol reduces senescence‐associated secretory phenotype by SIRT1/NF‐&kgr;B pathway in gut of the annual fish Nothobranchius guentheri

  2018cited by this paper
• Deficiency of Atg6 impairs beneficial effect of metformin on intestinal stem cell aging in Drosophila.

  2018cited by this paper
• Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome.

  2018cited by this paper
• Late-life targeting of the IGF-1 receptor improves healthspan and lifespan in female mice

  2018cited by this paper
• Aspirin—another caloric-restriction mimetic

  2018cited by this paper
• Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: A systematic review and meta-analysis.

  2018cited by this paper
• The emerging field of senotherapeutic drugs.

  2018cited by this paper
• Metformin directly targets the H3K27me3 demethylase KDM6A/UTX

  2018cited by this paper
• Aspirin induces autophagy via inhibition of the acetyltransferase EP300

  2018cited by this paper
• Effect of resveratrol and pterostilbene on aging and longevity

  2018cited by this paper
• Oxidative stress, aging, and diseases

  2018cited by this paper
• Natural products with anti-aging potential: Affected targets and molecular mechanisms.

  2018cited by this paper
• Metformin treatment ameliorates diabetes‐associated decline in hippocampal neurogenesis and memory via phosphorylation of insulin receptor substrate 1

  2018cited by this paper
• A Perfect sTORm: The Role of the Mammalian Target of Rapamycin (mTOR) in Cerebrovascular Dysfunction of Alzheimer's Disease: A Mini-Review

  2018cited by this paper
• Lifespan extension without fertility reduction following dietary addition of the autophagy activator Torin1 in Drosophila melanogaster

  2018cited by this paper
• Targeting Mitochondria to Counteract Age-Related Cellular Dysfunction

  2018cited by this paper
• AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance.

  2017cited by this paper
• Glycation inhibitors extend yeast chronological lifespan by reducing advanced glycation end products and by back regulation of proteins involved in mitochondrial respiration.

  2017cited by this paper
• Aspirin increases metabolism through germline signalling to extend the lifespan of Caenorhabditis elegans

  2017cited by this paper
• Stress, cell senescence and organismal ageing.

  2017cited by this paper
• Targeting the SASP to combat ageing: Mitochondria as possible intracellular allies?

  2017cited by this paper
• Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging.

  2017cited by this paper
• RNA polymerase III limits longevity downstream of TORC1

  2017cited by this paper
• New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463

  2017cited by this paper
• The mechanisms of action of metformin

  2017cited by this paper
• Lasker Awards BenchMarks TOR , the Gateway to Cellular Metabolism , Cell Growth , and Disease

  2017cited by this paper
• Review of bioanalytical assays for the quantitation of various HDAC inhibitors such as vorinostat, belinostat, panobinostat, romidepsin and chidamine.

  2017cited by this paper
• HDAC inhibitors: A new promising drug class in anti-aging research.

  2017cited by this paper
• Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex.

  2017cited by this paper
• mTOR Inhibition and Cardiovascular Diseases: Dyslipidemia and Atherosclerosis

  2017cited by this paper
• Metformin as a Tool to Target Aging.

  2016cited by this paper
• Aspirin inhibits glucose-6-phosphate dehydrogenase activity in HCT 116 cells through acetylation: Identification of aspirin-acetylated sites

  2016cited by this paper
• A cell-based quantitative high-throughput image screening identified novel autophagy modulators.

  2016cited by this paper
• Age-related changes in AMPK activation: Role for AMPK phosphatases and inhibitory phosphorylation by upstream signaling pathways.

  2016cited by this paper
• Effects of exercise training and resveratrol on vascular health in aging.

  2016cited by this paper
• Discovery of piperlongumine as a potential novel lead for the development of senolytic agents

  2016cited by this paper
• mTOR inhibitors in cancer therapy

  2016cited by this paper
• The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging.

  2016cited by this paper
• Structure and Regulation of AMPK.

  2016cited by this paper
• Potential therapeutic effects of mTOR inhibition in atherosclerosis.

  2016cited by this paper
• Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.

  2016cited by this paper
• Rapamycin in aging and disease: maximizing efficacy while minimizing side effects

  2016cited by this paper
• Resveratrol and Lifespan in Model Organisms.

  2016cited by this paper
• Metformin Prevents Cisplatin-Induced Cognitive Impairment and Brain Damage in Mice

  2016cited by this paper
• Does Longer Lifespan Mean Longer Healthspan?

  2016cited by this paper
• Gerosuppression by pan-mTOR inhibitors

  2016cited by this paper
• Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status

  2016cited by this paper
• Long-term treatment with pegvisomant as monotherapy in patients with acromegaly: experience from ACROSTUDY.

  2015cited by this paper
• Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect.

  2015cited by this paper
• Rapamycin-mediated mTORC2 inhibition is determined by the relative expression of FK506-binding proteins

  2015cited by this paper
• Lifespan and healthspan extension by resveratrol.

  2015cited by this paper
• Biological theories of aging.

  2015cited by this paper
• The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs

  2015cited by this paper
• Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice

  2015cited by this paper
• Influence of non-steroidal anti-inflammatory drugs on Drosophila melanogaster longevity

  2015cited by this paper
• The Ras-Erk-ETS-Signaling Pathway Is a Drug Target for Longevity

  2015cited by this paper
• Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents

  2015cited by this paper
• Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program)

  2015cited by this paper
• Longevity Pathways (mTOR, SIRT, Insulin/IGF-1) as Key Modulatory Targets on Aging and Neurodegeneration.

  2015cited by this paper
• Dissecting the Mechanisms Underlying Unusually Successful Human Health Span and Life Span.

  2015cited by this paper
• Mechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer Cells

  2014cited by this paper
• Caloric restriction mimetics: towards a molecular definition

  2014cited by this paper
• Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction

  2014cited by this paper
• Metformin Inhibits Monocyte-to-Macrophage Differentiation via AMPK-Mediated Inhibition of STAT3 Activation: Potential Role in Atherosclerosis

  2014cited by this paper
• Structural basis for AMPK activation: natural and synthetic ligands regulate kinase activity from opposite poles by different molecular mechanisms.

  2014cited by this paper
• Mice Fed Rapamycin Have an Increase in Lifespan Associated with Major Changes in the Liver Transcriptome

  2014cited by this paper
• Long-term efficacy and safety of pegvisomant in combination with long-acting somatostatin analogs in acromegaly.

  2014cited by this paper
• AMPK--sensing energy while talking to other signaling pathways.

  2014cited by this paper
• Signaling crosstalk between the mTOR complexes

  2014cited by this paper
• Longevity, aging and rapamycin

  2014cited by this paper
• Evidence for a Common Mechanism of SIRT1 Regulation by Allosteric Activators

  2013cited by this paper
• Aging is not programmed

  2013cited by this paper
• The GH/IGF-1 axis in ageing and longevity

  2013cited by this paper
• mTOR is a key modulator of ageing and age-related disease

  2013cited by this paper
• Characterization of Torin2, an ATP-competitive inhibitor of mTOR, ATM, and ATR.

  2013cited by this paper
• Sirt1 activation by resveratrol is substrate sequence-selective

  2013cited by this paper
• Rapamycin extends murine lifespan but has limited effects on aging.

  2013cited by this paper
• Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on high-fat, high-sugar diet.

  2013cited by this paper
• An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice

  2013cited by this paper
• Aspirin Inhibits Oxidant Stress, Reduces Age-Associated Functional Declines, and Extends Lifespan of Caenorhabditis elegans

  2013cited by this paper
• Metformin Retards Aging in C. elegans by Altering Microbial Folate and Methionine Metabolism

  2013cited by this paper
• Synthetic scaffolds increased resveratrol biosynthesis in engineered yeast cells.

  2012cited by this paper
• Effects of resveratrol on longevity, cognitive ability and aging-related histological markers in the annual fish Nothobranchius guentheri.

  2012cited by this paper
• SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function.

  2012cited by this paper
• Low-dose aspirin and cancer mortality: a meta-analysis of randomized trials.

  2012cited by this paper
• The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase

  2012cited by this paper
• Local administration of growth hormone stimulates tendon collagen synthesis in elderly men.

  2012cited by this paper
• Activation of mTOR/p70S6 kinase by ANG II inhibits insulin-stimulated endothelial nitric oxide synthase and vasodilation.

  2012cited by this paper
• Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer

  2012cited by this paper
• AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan

  2011cited by this paper
• The telomerase activator TA‐65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence

  2011cited by this paper
• A review and appraisal of the DNA damage theory of ageing.

  2011cited by this paper
• A gain-of-function screen identifies wdb and lkb1 as lifespan-extending genes in Drosophila.

  2011cited by this paper
• The AMPK signalling pathway coordinates cell growth, autophagy and metabolism

  2011cited by this paper
• Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?

  2011cited by this paper
• A Natural Product Telomerase Activator As Part of a Health Maintenance Program

  2011cited by this paper
• Estimating the future healthcare costs of an aging population in the UK: expansion of morbidity and the need for preventative care.

  2011cited by this paper
• Structure of Mammalian AMPK and its regulation by ADP

  2011cited by this paper
• Absence of effects of Sir2 over-expression on lifespan in C. elegans and Drosophila

  2011cited by this paper

• Endogenous chondroitin extends the lifespan and healthspan in C. elegans

  2024cites this paper
• The Role of Systemic Filtrating Organs in Aging and Their Potential in Rejuvenation Strategies

  2022cites this paper
• Anti-Aging Effect of Metformin: A Molecular and Therapeutical Perspective.

  2020cites this paper
• Biological Responses to the Consumption of Non-Nutritional Sweeteners

  2020cites this paper
• Exercise and the Cisd2 Prolongevity Gene: Two Promising Strategies to Delay the Aging of Skeletal Muscle

  2020cites this paper